Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial-Reference-Cited by-同舟云学术

Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial

Published:2020-05 Issue:5 Volume:5 Page:465-474
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Rullier Eric,Vendrely Véronique,Asselineau Julien,Rouanet Philippe,Tuech Jean-Jacques,Valverde Alain,de Chaisemartin Cecile,Rivoire Michel,Trilling Bertrand,Jafari Mehrdad,Portier Guillaume,Meunier Bernard,Sieleznieff Igor,Bertrand Martin,Marchal Frédéric,Dubois Anne,Pocard Marc,Rullier Anne,Smith Denis,Frulio Nora,Frison Eric,Denost Quentin

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results;Habr-Gama;Ann Surg,2004

2. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer;Maas;J Clin Oncol,2011

3. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial;Garcia-Aguilar;Lancet Oncol,2015

4. Thirty-day postoperative mortality after colorectal surgery in England;Morris;Gut,2011

5. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial;van der Pas;Lancet,2013

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the local excision strategy for rectal cancer after chemoradiotherapy: Surgical and oncological results;European Journal of Surgical Oncology;2024-11

2. Colorectal cancer: Recent advances in management and treatment;World Journal of Clinical Oncology;2024-09-24

3. Watch and Wait is Changing: We Need to Change How We Count Costs;Annals of Surgical Oncology;2024-09-02

4. ‘Folfirinox’ chemotherapy combined with contact x-ray brachytherapy 50 kVp and ‘CAP50’ chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study;Cancer/Radiothérapie;2024-08

5. Predicting the response to neoadjuvant chemoradiation for rectal cancer using nomograms based on MRI tumour regression grade;Cancer/Radiothérapie;2024-08